coronary artery disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female, aged 18 years or more; 2. Unstable angina; 3. Stable angina; 4. Non-ST segment elevation myocardial infarction (nstemi), with stable status within 3 days hospitalization; 5. Acute ST-segment elevation myocardial infarction, with stable status within 3 days hospitalization; 6. Ischemic cardiomyopathy; 7. Established Coronary Heart Disease; 8. Provision of written informed consent.
Exclusion criteria
Exclusion criteria: 1. Have cardiogenic shock; 2. Have unstable decompensated heart failure; 3. Continuously or temporarily accepting ßreceptor agonist as treatment; 4. Symptomatic bradycardia or hypotension (heart rate0.24s or systolic pressure<100mmHg. 8. Forbidden to use ß-block or allergic toß-block or components; 9. Pregnancy or breastfeeding or planned pregnancy, or women of childbearing age without taking reliable methods of contraception; 10. Concurrent participation in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart Rat; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease history;Vital signs;Regular blood/ Blood chemistry test;The ß-blocker usage status;The adverse events;ECG examination;Concomitant medicine;Physical examinatio; | — |
Countries
China